New study focuses on personalized therapies for people with severe asthma
A new phase 2 clinical trial of multiple therapies for severe asthma is underway in Northeast Ohio, with a focus on personalized therapies based on genetics, family history, lifestyle and environmental factors.
The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE) study, sponsored by the National Heart, Lung and Blood Institute (NHBLI), is enrolling patients at Cleveland Clinic and University Hospitals Rainbow Babies & Children s Hospital.
The multicenter study involves 30 clinical sites in the United States, Canada and the United Kingdom that will collectively enroll 650 adult and 150 adolescent volunteers, age 12 and over. Prospective participants will be patients with poorly controlled asthma or frequent asthma attacks.
New research aims to improve treatments and outcomes for people with severe asthma eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.